Sato K, Kato T, Moriyama M
Department of Urology, Akita University School of Medicine, Japan.
Nihon Hinyokika Gakkai Zasshi. 1992 Dec;83(12):1957-63. doi: 10.5980/jpnjurol1989.83.1957.
We analyzed the alteration of int-2, c-erbB-2 and EGFR genes in 32 cases of transitional cell carcinoma of the urinary tract, 15 cases of renal cell carcinoma and 14 cases of prostatic carcinoma by Southern blot hybridization method. Three- to 12 fold amplification of int-2 gene was observed in 4 (12.5%) of 32 transitional cell carcinomas. Of these 4 cases 3 were G3 tumor with muscle invasion and the remaining was G1, pTa tumor with subsequent recurrence of multiple tumors. The other 2 cases (6.3%) with invasive transitional cell carcinoma showed amplification of c-erbB-2 gene. Neither amplification nor gross rearrangement of EGFR gene was detected in transitional cell carcinoma. On the other hand, renal cell carcinomas and prostatic carcinomas had neither amplification nor gross rearrangement of these 3 genes. These results suggest that the int-2 gene located in chromosome locus 11q13 and the c-erbB-2 gene have a specific role in carcinogenesis and in progression of transitional cell carcinoma through their gene amplifications.
我们采用Southern印迹杂交法分析了32例泌尿道移行细胞癌、15例肾细胞癌和14例前列腺癌中int-2、c-erbB-2和EGFR基因的改变。在32例移行细胞癌中的4例(12.5%)观察到int-2基因有3至12倍的扩增。在这4例中,3例为伴有肌肉浸润的G3肿瘤,其余1例为G1、pTa肿瘤且随后出现多发肿瘤复发。另外2例浸润性移行细胞癌(6.3%)显示c-erbB-2基因扩增。在移行细胞癌中未检测到EGFR基因的扩增或大片段重排。另一方面,肾细胞癌和前列腺癌中这3个基因均未出现扩增或大片段重排。这些结果表明,位于染色体11q13位点的int-2基因和c-erbB-2基因通过其基因扩增在移行细胞癌的发生和进展中具有特定作用。